Clinical Trial Update: HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON CANADA [NA]

View source ↗

Summary

The NCT02159794 trial investigating transfemoral transcatheter aortic valve replacement for severe aortic stenosis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Snippet

Sponsor: HLT Inc. | Conditions: Severe Aortic Stenosis | NA | Status: WITHDRAWN